Clinical Trial Update: Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Ozurdex for the combination of pseudophakic cystoid macular edema and diabetic macular edema after cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Pseudophakic Cystoid Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Northern California Retina Vitreous Associates | Conditions: Pseudophakic Cystoid Macular Edema,, Diabetic Macular Edema | Phase 2 | Status: COMPLETED